Exabis Library
Welcome to the e-CCO Library!
P099: Postprandial intestinal motility and related physiology in active small-bowel Crohn’s disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P099: Serum proteomic analysis reveals novel biomarkers associated with disease activity in pediatric patients with Crohn’s disease
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P100 CD161 levels are reduced in all subpopulations of T-cell colonic mucosal lymphocytes in inflammatory bowel disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P100: Atypical Anti-Neutrophil Cytoplasmatic Antibodies Are Antibodies Against Neutrophil Extracellular Traps: A Novel Pathophysiological Mechanism In Ulcerative Colitis
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P100: Effects of a narrow spectrum kinase inhibitor and selective kinase inhibitors on the intestinal pro-inflammatory immune response in ulcerative colitis
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P100: Guanosine prevents nuclear factor-κB nuclear translocation ameliorating experimental colitis in rats
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P100: Higher yield of serrated and adenomatous dysplasia detected with chromoendoscopy when compared with high-definition in patients with Primary Sclerosing Cholangitis and Inflammatory colitis.
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P100: Intestinal epithelial cells under endoplasmic reticulum stress boosts serine proteolytic activity and modulates barrier function
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P100: Real-world data: the incidence, diagnosis, and management outcomes of patients with immunotherapy-related colitis in two tertiary centres
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P100: Serum inflammatory protein profiling to corroborate selection of therapy naïve moderate-to-severe pediatric Crohn’s disease patients eligible for first-line infliximab treatment
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P101 Biomarkers of elastin degradation are associated with clinical and biochemically active disease in Crohn’s disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P101: Circulating MicroRNA-16 in Inflammatory Bowel Disease Patients - Potential Biomarker to Assess Inflammation
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P101: Fecal calprotectin is increased among patients with pouchitis and increases with increasing endoscopic subscores: Real-world data from a prospectively collected database
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P101: Functional translation of IBD-associated genetic variation in patient-derived intestinal epithelial cells
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P101: Innate immunity and Crohn’s disease recurrence after surgery
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P101: Interleukin-13 induces polarity defects in the intestinal epithelia
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P101: Isosteviol Attenuates Dextran Sulfate Sodium-Induced Colitis by Maintaining the Intestinal Barrier Through PDK1/AKT/NF-κB Signaling
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P101: Simple five-point classification of MR enterocolonography for Crohn’s disease based on enteroscopic findings
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P102 Host gene background and concentration influence the butyrate effect on modulating IECs proliferation
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P102: α-Defensins(αDef) 1-3 are specific plasmatic markers for Crohn’s disease (CD) at diagnosis and tissue α-Def 5 methylation is a pathogenic mechanism for αDef-5 down regulation in CD.
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM